Kobayashi Pharmaceutical Co. Ltd
| Preis (2026-07-17) | 52W Hoch | 52W Tief |
| 28.823 EUR | 31,733 EUR | 26,862 EUR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - EUR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 74.338.764 | - | - |
Beschreibung
(automatisch übersetzt)
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
| Allgemein | Profitabilität | ||
|---|---|---|---|
| Industriesektor ? | Haushaltsprodukte | Operative Marge [%] ? | - |
| Marktkapitalisierung ? | - EUR | ROIC [%] ? | - |
| Enterprise Value ? | - EUR | ROIC/WACC ? | - |
| Bewertung | |||
| KGV [TTM] ? | - | EV/FCFF [TTM] ? | - |
| KGV [Forward] ? | - | EV/Sales [TTM] ? | - |
| KUV [TTM] ? | - | EV/EBITDA [TTM] ? | - |
| KBV [TTM] ? | - | ||
| Finanzielle Risiken und Liquidität | |||
| Künstl. Bonität ? | - | Zinsdeckungsgrad ? | - |
| Verschuldungsgrad [Buch] ? | - | Cash Ratio - L1 ? | - |
| Verschuldungsgrad [Markt] ? | - | Quick Ratio - L2 ? | - |
| Current Ratio - L3 ? | - | ||
| Dividenden und Aktienrückkäufe | |||
| Vergangene Jahresdividende ? | - EUR | Ausschüttungsquote ? | - % |
| Erwartete Jahresdividende ? | - EUR | Erwartete Dividendenrendite ? | - % |
| Netto Aktienrückkäufe [TTM] ? | - JPY | Effektive Ausschüttungsquote ? | - % |
| Dividendenauszahlung [TTM] ? | - JPY | Effektive Auszahlungsrendite ? | - % |
| Netto Gesamtauszahlung [TTM] ? | - JPY | ||
Kennzahlen
Gewinn/Verlust
Cash Flow
Dividenden & Aktienrückkäufe
Bilanz
Vergleichbare Unternehmen
| Name | Takani Score ? | Marktkapitalisierung | Industriesektor | Land/Region | KGV TTM | Forward KGV ? | |
|---|---|---|---|---|---|---|---|
| POLA Orbis Holdings Inc | 41,7 | 1.791.685.395,917 USD | Haushaltsprodukte | Japan | 30.87 | 20.37 | |
| Lion Corporation | 49,91 | 2.268.666.368 USD | Haushaltsprodukte | Japan | 22.16 | - | |
![]() | Kose Corp ADR | 36,46 | 1.771.585.792 USD | Haushaltsprodukte | Japan | 18.92 | 18.21 |
![]() | Shiseido Company Ltd | 26,72 | 7.484.855.808 USD | Haushaltsprodukte | Japan | - | 29.5 |
![]() | Unicharm Corp | 55,04 | 10.118.305.792 USD | Haushaltsprodukte | Japan | 26.73 | 19.84 |
![]() | Kao Corporation | 46,57 | 18.934.153.216 USD | Haushaltsprodukte | Japan | 29.07 | 22.12 |
| Giant Biogene Holding Co Ltd | 67,13 | 3.825.769.723,494 USD | Haushaltsprodukte | China | 13.51 | 10.16 | |
![]() | Inter Parfums Inc | 87,44 | 3.930.203.648 USD | Haushaltsprodukte | USA | 22.81 | 24.94 |
| LG Household & Healthcare | 27,85 | 3.669.836.536,218 USD | Haushaltsprodukte | Südkorea | - | 11.72 | |
![]() | Vinda International Holdings Ltd | 30 | 3.597.686.814,72 USD | Haushaltsprodukte | Hong Kong | 111.67 | 27.4 |





